title: [Invasive candidosis in intensive care unit patients].
abstract: The incidence of invasive candidosis is increasing worldwide and the mortality is high. In the intensive care unit diagnostic measurements, correct evaluation of the findings and the right indication for antifungal treatment remain problematic. So determination of potential risk factors is very important. The therapeutic use of antifungal drugs is often limited by important disadvantages like inadequate spectrum, application form or side effects. New antifungals give hope for the near future.
authors.affiliation: Neurologisches Rehabilitationszentrum Greifswald, Karl-Liebknecht-Ring 26A, D-17491 Greifswald, Deutschland. a.gloeckner@nrz-greifswald.de
authors.forename: A
authors.initials: A
authors.lastname: Glöckner
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use; D002177:Candidiasis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D007362:Intensive Care Units; D012307:Risk Factors
chemical_list: D000935:Antifungal Agents
vernacular_title: Systemische Candida-Infektionen bei Intensivpatienten.